CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-05 | Sheena Jonathan Director | Sale 10b5-1 | −1,028 | $88.37 | $91K | 463,585 |
| 2024-03-05 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale | −2,160 | $88.37 | $191K | 204,218 |
| 2024-03-05 | Chapman Steven Leonard CEO AND PRESIDENT | Sale | −9,326 | $88.37 | $824K | 246,957 |
| 2024-03-05 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale | −2,826 | $88.37 | $250K | 70,646 |
| 2024-03-05 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale | −18 | $87.33 | $2K | 200,494 |
| 2024-03-05 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale | −2,227 | $88.37 | $197K | 198,267 |
| 2024-03-05 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale | −15 | $87.37 | $1K | 114,486 |
| 2024-03-05 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale | −1,823 | $88.37 | $161K | 112,663 |
| 2024-03-05 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −8 | $87.25 | $698 | 1,076,652 |
| 2024-03-05 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −1,004 | $88.37 | $89K | 1,075,648 |
| 2024-03-05 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −73,788 | $86.88 | $6.4M | 976,248 |
| 2024-03-05 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −96,977 | $87.49 | $8.5M | 879,271 |
| 2024-03-05 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −13,743 | $88.64 | $1.2M | 865,528 |
| 2024-03-05 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −5,492 | $89.40 | $491K | 860,036 |
| 2024-03-01 | Sheena Jonathan Director | Grant or award | +1,028 | 464,613 | ||
| 2024-03-01 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Grant or award | +4,104 | 1,076,660 | ||
| 2024-03-01 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Grant or award | +2,160 | 206,378 | ||
| 2024-03-01 | Chapman Steven Leonard CEO AND PRESIDENT | Grant or award | +9,326 | 256,283 | ||
| 2024-03-01 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Grant or award | +2,826 | 73,472 | ||
| 2024-03-01 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Grant or award | +2,329 | 197,306 |
Page 78 of 85 · 1,682 trades